ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,350Medicare Part D Prescriptions Filled, Including Refills

Rank: 621 out of 4623

$504K Total Retail Price of All Prescriptions

Rank: 727 out of 4623

412 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 412 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 7,021 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
AMLODIPINE BESYLATE 680 522 1 5
HYDROCHLOROTHIAZIDE 395 290 2 10
ENALAPRIL MALEATE 391 301 3 41
SIMVASTATIN 338 269 4 2
OMEPRAZOLE 337 274 5 7
METFORMIN HCL 266 217 6 6
ATORVASTATIN CALCIUM 256 219 7 12
TRAMADOL HCL 205 159 8 15
FUROSEMIDE 203 174 9 8
LISINOPRIL 201 140 10 4
METOPROLOL TARTRATE 195 167 11 9
ATENOLOL 194 167 12 28
FAMOTIDINE 186 119 13 82
PRAVASTATIN SODIUM 171 126 14 11
LEVOTHYROXINE SODIUM 168 121 15 1
LIPITOR 154 125 16 100
METOPROLOL SUCCINATE 143 92 17 13
GABAPENTIN 138 94 18 16
GLYBURIDE MICRONIZED 136 107 R 19 205
NOVOLIN N 132 87 20 237
ISOSORBIDE MONONITRATE ER 127 79 21 60
LOSARTAN POTASSIUM 127 101 21 21
WARFARIN SODIUM 122 89 23 24
NEXIUM 119 107 24 17
DOXAZOSIN MESYLATE 117 91 25 98
KLOR-CON 8 116 86 26 246
ADVAIR DISKUS 114 93 27 62
FENOFIBRATE 96 75 28 54
NAPROXEN 85 61 29 63
GLYBURIDE 83 68 R 30 59
DILTIAZEM ER 83 58 30 179
COMBIVENT 83 62 30 162
NITROSTAT 80 66 33 263
CARVEDILOL 79 61 34 25
PLAVIX 78 50 35 45
PANTOPRAZOLE SODIUM 78 50 35 35
AMILORIDE-HYDROCHLOROTHIAZIDE 71 47 37 288
ACETAMINOPHEN-CODEINE 70 43 S3 38 144
CLOPIDOGREL 68 45 39 31
GLYBURIDE-METFORMIN HCL 63 35 R 40 56
CLONIDINE HCL 59 46 41 40
HYDRALAZINE HCL 59 46 41 99
INSULIN SYRINGE 55 22 43 85
KLOR-CON 10 53 37 44 187
VERAPAMIL ER 50 49 45 96
ALLOPURINOL 50 41 45 37
NOVOLIN 70-30 50 40 45 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 12, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.